Keyphrases
30-day Mortality
21%
Adjusted Odds Ratio
18%
Adverse Effects
16%
Aggressive Therapy
32%
Anemia
100%
Antibiotic Administration
32%
Antibiotics
20%
Blood Culture
32%
Breast Enlargement
32%
Chronic Kidney Disease
85%
Concurrent Diagnoses
32%
Confidence Interval
22%
Congestive Heart Failure
96%
COVID-19
30%
COVID-19 Patients
42%
Culture Positivity
32%
D-penicillamine
32%
Delta Variant
15%
Diabetic
32%
Diagnostic Delay
32%
Diagnostic Value
64%
Discharge Strategies
32%
Early Discharge
32%
Emergency Department
32%
Enlargement
16%
Erythropoietin
67%
Heart Failure
32%
Hemoglobin
19%
Home Therapy
32%
Hospital Stay
21%
Hospitalization
45%
In-hospital Outcomes
15%
Independent Predictors of Mortality
16%
Intervention Group
32%
Intravenous Iron
64%
Lactate Dehydrogenase
32%
Medical Patients
64%
Mild Anaemia
16%
Moderate to Severe
12%
Non-diabetic
32%
Palliative Extubation
32%
Prognostic Value
64%
Readmission
32%
Renal Failure
32%
Respiration
21%
Scleroderma
24%
Serum Lactate Dehydrogenase
32%
Severe COVID-19 Patients
32%
Single-center Study
32%
Thrombocytosis
32%
Medicine and Dentistry
Adverse Event
16%
Anemia
67%
Artificial Respiration
7%
Attitude
32%
Biological Marker
12%
Breast Enlargement
32%
Breast Reduction
8%
Cancer
5%
Chronic Disease
32%
Chronic Kidney Disease
50%
Congestive Heart Failure
59%
COVID-19
64%
Diagnosis
64%
Diagnostic Delay
32%
Diagnostic Procedure
8%
Disease
60%
Drug Therapy
40%
Emergency Department
32%
Erythropoietin
35%
Extubation
32%
Final Diagnosis
6%
Heart Failure
34%
Hematologic Malignancy
6%
Home Oxygen Therapy
32%
Infection
22%
Iron Sucrose
7%
Lactate Dehydrogenase
32%
Mortality Rate
7%
Odds Ratio
18%
Penicillamine
32%
Prevalence
7%
Renal Failure
32%
Rheumatic Disease
5%
Scleroderma
24%
Thrombocytosis
32%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
16%
Adverse Event
16%
Adverse Outcome
16%
Anemia
99%
Antibiotic Agent
18%
Antibiotics
32%
Biological Marker
12%
Chronic Kidney Failure
82%
Congestive Heart Failure
91%
Delta Variant
16%
Diabetes Mellitus
32%
Disease
84%
Disease Severity
16%
Erythropoietin
67%
Heart Failure
32%
Hematologic Malignancy
6%
Infection
27%
Inflammation
5%
Iron Saccharate
10%
Kidney Failure
32%
Lactate Dehydrogenase
32%
Mortality Rate
19%
Penicillamine
32%
Population Study
16%
Prevalence
7%
Rheumatic Disease
5%
Scleroderma
24%
Terminal Disease
8%
Thrombocytosis
32%